Header Logo

Connection

NIKOLAOS FRANGOGIANNIS to Myocardial Infarction

Back to Details
This is a "connection" page, showing publications NIKOLAOS FRANGOGIANNIS has written about Myocardial Infarction.
NIKOLAOS FRANGOGIANNIS
Connection Strength
21.987
Myocardial Infarction
  1. Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction". Circulation. 2024 03 19; 149(12):e962-e963.
    View in: PubMed
    Score: 0.499
  2. TGF-? as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities. Expert Opin Ther Targets. 2024 Jan-Feb; 28(1-2):45-56.
    View in: PubMed
    Score: 0.497
  3. Targeting galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy. Cardiovasc Res. 2023 11 25; 119(15):2495-2496.
    View in: PubMed
    Score: 0.489
  4. Protective effects of macrophage-specific integrin a5 in myocardial infarction are associated with accentuated angiogenesis. Nat Commun. 2023 Nov 20; 14(1):7555.
    View in: PubMed
    Score: 0.488
  5. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction. Circulation. 2023 09 12; 148(11):882-898.
    View in: PubMed
    Score: 0.475
  6. Macrophages in myocardial infarction. Am J Physiol Cell Physiol. 2022 10 01; 323(4):C1304-C1324.
    View in: PubMed
    Score: 0.450
  7. The role of endogenous Smad7 in regulating macrophage phenotype following myocardial infarction. FASEB J. 2022 07; 36(7):e22400.
    View in: PubMed
    Score: 0.443
  8. Differential effects of Smad2 and Smad3 in regulation of macrophage phenotype and function in the infarcted myocardium. J Mol Cell Cardiol. 2022 10; 171:1-15.
    View in: PubMed
    Score: 0.443
  9. Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction. Cells. 2022 04 20; 11(9).
    View in: PubMed
    Score: 0.437
  10. Smad-dependent pathways in the infarcted and failing heart. Curr Opin Pharmacol. 2022 06; 64:102207.
    View in: PubMed
    Score: 0.436
  11. Platelet-derived growth factor (PDGF) therapy in myocardial infarction: Challenges and opportunities. Int J Cardiol. 2021 10 15; 341:74-75.
    View in: PubMed
    Score: 0.418
  12. Collagen denaturation in the infarcted myocardium involves temporally distinct effects of MT1-MMP-dependent proteolysis and mechanical tension. Matrix Biol. 2021 05; 99:18-42.
    View in: PubMed
    Score: 0.411
  13. The role of Smad signaling cascades in cardiac fibrosis. Cell Signal. 2021 01; 77:109826.
    View in: PubMed
    Score: 0.395
  14. Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of nonreperfused myocardial infarction. Am J Physiol Heart Circ Physiol. 2020 11 01; 319(5):H948-H964.
    View in: PubMed
    Score: 0.391
  15. Chemokines in Myocardial Infarction. J Cardiovasc Transl Res. 2021 02; 14(1):35-52.
    View in: PubMed
    Score: 0.383
  16. How do endosomal Toll-like receptors sense and extend ischaemic myocardial injury? Cardiovasc Res. 2019 10 01; 115(12):1687-1689.
    View in: PubMed
    Score: 0.367
  17. S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges. Eur Heart J. 2019 08 21; 40(32):2724-2726.
    View in: PubMed
    Score: 0.364
  18. The cell biological basis for primary unloading in acute myocardial infarction. Int J Cardiol. 2019 10 15; 293:45-47.
    View in: PubMed
    Score: 0.360
  19. Macrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation. Circ Res. 2019 06 21; 125(1):55-70.
    View in: PubMed
    Score: 0.357
  20. Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart. J Mol Cell Cardiol. 2019 07; 132:84-97.
    View in: PubMed
    Score: 0.357
  21. Aging, cardiac repair and Smad3. Aging (Albany NY). 2018 09 20; 10(9):2230-2232.
    View in: PubMed
    Score: 0.341
  22. Targeting mitochondrial calcium transport in myocardial infarction. Hellenic J Cardiol. 2018 Jul - Aug; 59(4):223-225.
    View in: PubMed
    Score: 0.335
  23. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br J Pharmacol. 2018 05; 175(9):1377-1400.
    View in: PubMed
    Score: 0.329
  24. The Cellular Origin of Activated Fibroblasts in the Infarcted and Remodeling Myocardium. Circ Res. 2018 02 16; 122(4):540-542.
    View in: PubMed
    Score: 0.328
  25. Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium. Circulation. 2018 02 13; 137(7):707-724.
    View in: PubMed
    Score: 0.323
  26. Fibroblasts and the extracellular matrix in right ventricular disease. Cardiovasc Res. 2017 Oct 01; 113(12):1453-1464.
    View in: PubMed
    Score: 0.319
  27. The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest. 2017 May 01; 127(5):1600-1612.
    View in: PubMed
    Score: 0.310
  28. Immune cells in repair of the infarcted myocardium. Microcirculation. 2017 01; 24(1).
    View in: PubMed
    Score: 0.303
  29. The role of a-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol Basis Dis. 2017 01; 1863(1):298-309.
    View in: PubMed
    Score: 0.300
  30. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016 06 24; 119(1):91-112.
    View in: PubMed
    Score: 0.292
  31. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction. J Mol Cell Cardiol. 2015 Dec; 89(Pt B):223-31.
    View in: PubMed
    Score: 0.279
  32. Pathophysiology of Myocardial Infarction. Compr Physiol. 2015 Sep 20; 5(4):1841-75.
    View in: PubMed
    Score: 0.277
  33. Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regeneration. J Clin Invest. 2015 Aug 03; 125(8):2927-30.
    View in: PubMed
    Score: 0.274
  34. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. Transl Res. 2016 Jan; 167(1):152-66.
    View in: PubMed
    Score: 0.274
  35. Mediators secreted by myeloid cells may protect and repair the infarcted myocardium. Circ Res. 2015 Jun 19; 117(1):10-2.
    View in: PubMed
    Score: 0.272
  36. Inflammation in cardiac injury, repair and regeneration. Curr Opin Cardiol. 2015 May; 30(3):240-5.
    View in: PubMed
    Score: 0.270
  37. CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans. Cardiovasc Res. 2014 Jul 15; 103(2):217-27.
    View in: PubMed
    Score: 0.253
  38. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014 May; 11(5):255-65.
    View in: PubMed
    Score: 0.250
  39. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol. 2014 Mar; 63(3):185-95.
    View in: PubMed
    Score: 0.249
  40. Targeting the chemokines in cardiac repair. Curr Pharm Des. 2014; 20(12):1971-9.
    View in: PubMed
    Score: 0.246
  41. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol. 2014 May; 70:74-82.
    View in: PubMed
    Score: 0.245
  42. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol. 2013 Nov 01; 191(9):4838-48.
    View in: PubMed
    Score: 0.242
  43. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol. 2013 Nov 01; 305(9):H1363-72.
    View in: PubMed
    Score: 0.240
  44. Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest. 2013 Sep; 43(9):986-95.
    View in: PubMed
    Score: 0.237
  45. Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction. J Histochem Cytochem. 2013 Aug; 61(8):555-70.
    View in: PubMed
    Score: 0.236
  46. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol. 2012 Nov; 32(11):2598-608.
    View in: PubMed
    Score: 0.225
  47. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res. 2012 Dec; 5(6):837-47.
    View in: PubMed
    Score: 0.225
  48. Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta. 2013 Apr; 1833(4):945-53.
    View in: PubMed
    Score: 0.225
  49. Monomeric C-reactive protein and inflammatory injury in myocardial infarction. Cardiovasc Res. 2012 Oct 01; 96(1):4-6.
    View in: PubMed
    Score: 0.223
  50. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012 Jan 06; 110(1):159-73.
    View in: PubMed
    Score: 0.214
  51. The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. J Am Coll Cardiol. 2011 Nov 29; 58(23):2424-6.
    View in: PubMed
    Score: 0.213
  52. The cellular specificity of leptin-mediated actions in the infarcted heart. Cardiovasc Res. 2011 Jan 01; 89(1):9-11.
    View in: PubMed
    Score: 0.198
  53. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res. 2010 Aug 06; 107(3):418-28.
    View in: PubMed
    Score: 0.192
  54. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol. 2010 May; 176(5):2177-87.
    View in: PubMed
    Score: 0.190
  55. Syndecan-1: a critical mediator in cardiac fibrosis. Hypertension. 2010 Feb; 55(2):233-5.
    View in: PubMed
    Score: 0.187
  56. Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res. 2009 Nov 06; 105(10):973-83.
    View in: PubMed
    Score: 0.183
  57. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol. 2010 Mar; 48(3):504-11.
    View in: PubMed
    Score: 0.181
  58. The immune system and cardiac repair. Pharmacol Res. 2008 Aug; 58(2):88-111.
    View in: PubMed
    Score: 0.168
  59. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol. 2008 Jul; 173(1):57-67.
    View in: PubMed
    Score: 0.167
  60. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol. 2008 Apr 08; 51(14):1384-92.
    View in: PubMed
    Score: 0.165
  61. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol. 2008 Feb 15; 180(4):2625-33.
    View in: PubMed
    Score: 0.164
  62. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation. 2007 Nov 06; 116(19):2127-38.
    View in: PubMed
    Score: 0.160
  63. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets. 2007 Jun; 6(2):101-7.
    View in: PubMed
    Score: 0.156
  64. The role of the thrombospondins in healing myocardial infarcts. Cardiovasc Hematol Agents Med Chem. 2007 Jan; 5(1):21-7.
    View in: PubMed
    Score: 0.151
  65. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol. 2006 Dec 05; 48(11):2315-23.
    View in: PubMed
    Score: 0.150
  66. The mechanistic basis of infarct healing. Antioxid Redox Signal. 2006 Nov-Dec; 8(11-12):1907-39.
    View in: PubMed
    Score: 0.150
  67. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007 May 01; 74(2):184-95.
    View in: PubMed
    Score: 0.149
  68. Identification of mast cells in the cellular response to myocardial infarction. Methods Mol Biol. 2006; 315:91-101.
    View in: PubMed
    Score: 0.141
  69. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem. 2006; 13(16):1877-93.
    View in: PubMed
    Score: 0.141
  70. Impact of myocardial structure and function postinfarction on diastolic strain measurements: implications for assessment of myocardial viability. Am J Physiol Heart Circ Physiol. 2006 Feb; 290(2):H724-31.
    View in: PubMed
    Score: 0.139
  71. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation. 2005 Jun 07; 111(22):2935-42.
    View in: PubMed
    Score: 0.136
  72. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005 Apr 29; 96(8):881-9.
    View in: PubMed
    Score: 0.134
  73. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol. 2005 Jan; 205(1):102-11.
    View in: PubMed
    Score: 0.132
  74. Vascular mural cells in healing canine myocardial infarcts. J Histochem Cytochem. 2004 Aug; 52(8):1019-29.
    View in: PubMed
    Score: 0.128
  75. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol. 2004 Feb; 164(2):665-77.
    View in: PubMed
    Score: 0.124
  76. BAK contributes critically to necrosis and infarct generation during reperfused myocardial infarction. J Mol Cell Cardiol. 2023 11; 184:1-12.
    View in: PubMed
    Score: 0.120
  77. Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy. 2003 Sep; 2(3):242-56.
    View in: PubMed
    Score: 0.120
  78. MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am J Physiol Heart Circ Physiol. 2003 Aug; 285(2):H483-92.
    View in: PubMed
    Score: 0.117
  79. Smad7 effects on TGF-? and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure. J Clin Invest. 2022 02 01; 132(3).
    View in: PubMed
    Score: 0.108
  80. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002 Jan; 53(1):31-47.
    View in: PubMed
    Score: 0.107
  81. Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem. 2002 Jan; 50(1):71-9.
    View in: PubMed
    Score: 0.107
  82. Guidelines for in vivo mouse models of myocardial infarction. Am J Physiol Heart Circ Physiol. 2021 12 01; 321(6):H1056-H1073.
    View in: PubMed
    Score: 0.105
  83. Reperfused vs. nonreperfused myocardial infarction: when to use which model. Am J Physiol Heart Circ Physiol. 2021 07 01; 321(1):H208-H213.
    View in: PubMed
    Score: 0.103
  84. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res. 2019 06 01; 115(7):1117-1130.
    View in: PubMed
    Score: 0.090
  85. Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol. 2018 04 01; 314(4):H812-H838.
    View in: PubMed
    Score: 0.081
  86. Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure. Cardiovasc Pathol. 2017 Sep - Oct; 30:27-37.
    View in: PubMed
    Score: 0.078
  87. The Functional Pluralism of Fibroblasts in the Infarcted Myocardium. Circ Res. 2016 10 28; 119(10):1049-1051.
    View in: PubMed
    Score: 0.075
  88. Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res. 2010 Feb 19; 106(3):546-50.
    View in: PubMed
    Score: 0.046
  89. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res. 2007 May 01; 74(2):313-22.
    View in: PubMed
    Score: 0.038
  90. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006 Nov; 291(5):H2504-14.
    View in: PubMed
    Score: 0.036
  91. The role of the chemokines in myocardial ischemia and reperfusion. Curr Vasc Pharmacol. 2004 Apr; 2(2):163-74.
    View in: PubMed
    Score: 0.031
  92. Crossing Into the Next Frontier of Cardiac Extracellular Matrix Research. Circ Res. 2016 10 28; 119(10):1040-1045.
    View in: PubMed
    Score: 0.019
  93. Integrated multimodal-catheter imaging unveils principal relationships among ventricular electrical activity, anatomy, and function. Am J Physiol Heart Circ Physiol. 2008 Feb; 294(2):H1002-9.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.